Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 434

Similar articles for PubMed (Select 15631537)

1.

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.

Smith DH, Dubiel R, Jones M.

Am J Cardiovasc Drugs. 2005;5(1):41-50. Erratum in: Am J Cardiovasc Drugs. 2005;5(3):209.

PMID:
15631537
3.

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.

Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J.

J Clin Hypertens (Greenwich). 2001 Sep-Oct;3(5):283-91, 318. Erratum in: J Clin Hypertens (Greenwich) 2001 Nov-Dec;3(6):395.

PMID:
11588406
4.

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.

Chrysant SG, Marbury TC, Robinson TD.

J Hum Hypertens. 2003 Jun;17(6):425-32.

PMID:
12764406
5.

Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.

White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S.

Hypertension. 2011 Mar;57(3):413-20. doi: 10.1161/HYPERTENSIONAHA.110.163402. Epub 2011 Jan 31.

6.

Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension.

Giles TD, Oparil S, Silfani TN, Wang A, Walker JF.

J Clin Hypertens (Greenwich). 2007 Mar;9(3):187-95.

PMID:
17341994
7.
8.

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.

Vasc Health Risk Manag. 2011;7:701-8. doi: 10.2147/VHRM.S25743. Epub 2011 Nov 24.

9.
10.

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).

Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R; MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL).

Clin Ther. 2002 Jan;24(1):126-38.

PMID:
11833827
11.
12.

[Efficacy and safety of olmesartan medoxomil versus losartan potassium in Chinese patients with mild to moderate essential hypertension].

Zhu JR, Cai NS, Fan WH, Zhu DL, He B, Wu ZG, Ke YN, Guo JX, Ma H, Huang J, Li XL, Chen YZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):877-81. Chinese.

PMID:
17217710
13.

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

Malacco E, Omboni S, Mallion JM, Volpe M; ESPORT Study Group.

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.

PMID:
23430666
14.

Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.

Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R.

Am J Cardiovasc Drugs. 2007;7(5):361-72.

PMID:
17953475
16.

Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.

Omboni S, Malacco E, Mallion JM, Volpe M, Zanchetti A; Study Group.

J Hypertens. 2012 Jul;30(7):1468-77. doi: 10.1097/HJH.0b013e32835466ac.

PMID:
22573127
17.

Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin Drug Investig. 2007;27(8):545-58.

PMID:
17638395
18.
19.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
20.

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial Investigators.

Monterroso VH, Rodriguez Chavez V, Carbajal ET, Vogel DR, Aroca Martinez GJ, Garcia LH, Cuevas JH, Lara Teran J, Hitzenberger G, Leao Neves P, Middlemost SJ, Dumortier T, Bunt AM, Smith RD.

Adv Ther. 2000 Mar-Apr;17(2):117-31.

PMID:
11010055
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk